Cargando…
Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
PURPOSE: To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer. PATIENTS AND METHODS: A total of 106 inpatients w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174132/ https://www.ncbi.nlm.nih.gov/pubmed/25258522 http://dx.doi.org/10.2147/PPA.S67111 |
_version_ | 1782336308821098496 |
---|---|
author | Zhang, Jishui Xie, Shumin Liu, Jiahao Sun, Weilin Guo, Hui Hu, Yingbin Gao, Xin |
author_facet | Zhang, Jishui Xie, Shumin Liu, Jiahao Sun, Weilin Guo, Hui Hu, Yingbin Gao, Xin |
author_sort | Zhang, Jishui |
collection | PubMed |
description | PURPOSE: To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer. PATIENTS AND METHODS: A total of 106 inpatients with gastrointestinal cancer at Cangzhou Center Hospital were enrolled in this study. All were treated at Cangzhou Center Hospital from July 2013–March 2014. All participants self-administered the EORTC IN-PATSAT32 and EORTC Quality of Life Questionnaire – Core 30 (EORTC QLQ-C30). RESULTS: The Cronbach’s α coefficients were >0.70 for all scales of the EORTC IN-PATSAT32. Multitrait scaling analysis showed that all-item scale correlation coefficients met the standard of convergent validity, while only 50.0% met the standard of discriminant validity. A weak correlation was found between the scales and single items of the EORTC IN-PATSAT32 and EORTC QLQ-C30. CONCLUSION: The EORTC IN-PATSAT32 appears to be a reliable, valid, and acceptable instrument for measuring patient satisfaction among Chinese patients with gastrointestinal cancer. |
format | Online Article Text |
id | pubmed-4174132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41741322014-09-25 Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer Zhang, Jishui Xie, Shumin Liu, Jiahao Sun, Weilin Guo, Hui Hu, Yingbin Gao, Xin Patient Prefer Adherence Original Research PURPOSE: To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer. PATIENTS AND METHODS: A total of 106 inpatients with gastrointestinal cancer at Cangzhou Center Hospital were enrolled in this study. All were treated at Cangzhou Center Hospital from July 2013–March 2014. All participants self-administered the EORTC IN-PATSAT32 and EORTC Quality of Life Questionnaire – Core 30 (EORTC QLQ-C30). RESULTS: The Cronbach’s α coefficients were >0.70 for all scales of the EORTC IN-PATSAT32. Multitrait scaling analysis showed that all-item scale correlation coefficients met the standard of convergent validity, while only 50.0% met the standard of discriminant validity. A weak correlation was found between the scales and single items of the EORTC IN-PATSAT32 and EORTC QLQ-C30. CONCLUSION: The EORTC IN-PATSAT32 appears to be a reliable, valid, and acceptable instrument for measuring patient satisfaction among Chinese patients with gastrointestinal cancer. Dove Medical Press 2014-09-18 /pmc/articles/PMC4174132/ /pubmed/25258522 http://dx.doi.org/10.2147/PPA.S67111 Text en © 2014 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zhang, Jishui Xie, Shumin Liu, Jiahao Sun, Weilin Guo, Hui Hu, Yingbin Gao, Xin Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer |
title | Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer |
title_full | Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer |
title_fullStr | Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer |
title_full_unstemmed | Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer |
title_short | Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer |
title_sort | validation of eortc in-patsat32 for chinese patients with gastrointestinal cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174132/ https://www.ncbi.nlm.nih.gov/pubmed/25258522 http://dx.doi.org/10.2147/PPA.S67111 |
work_keys_str_mv | AT zhangjishui validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer AT xieshumin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer AT liujiahao validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer AT sunweilin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer AT guohui validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer AT huyingbin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer AT gaoxin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer |